Skip to main content
PMC home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 2002 Nov;110(11):1097–1103. doi: 10.1289/ehp.021101097

Developmental neurotoxicity of chlorpyrifos: what is the vulnerable period?

Dan Qiao 1, Frederic J Seidler 1, Stephanie Padilla 1, Theodore A Slotkin 1
PMCID: PMC1241065  PMID: 12417480

Abstract

Previously, we found that exposure of neonatal rats to chlorpyrifos (CPF) produced brain cell damage and loss, with resultant abnormalities of synaptic development. We used the same biomarkers to examine prenatal CPF treatment so as to define the critical period of vulnerability. One group of pregnant rats received CPF (subcutaneous injections in dimethyl sulfoxide vehicle) on gestational days (GD) 17-20, a peak period of neurogenesis; a second group was treated on GD9-12, the period of neural tube formation. In the GD17-20 group, the threshold for a reduction in maternal weight gain was 5 mg/kg/day; at or below that dose, there was no evidence (GD21) of general fetotoxicity as assessed by the number of fetuses or fetal body and tissue weights. Above the threshold, there was brain sparing (reduced body weight with an increase in brain/body weight ratio) and a targeting of the liver (reduced liver/body weight). Indices of cell packing density (DNA per gram of tissue) and cell number (DNA content) similarly showed effects only on the liver; however, there were significant changes in the protein/DNA ratio, an index of cell size, in fetal brain regions at doses as low as 1 mg/kg, below the threshold for inhibition of fetal brain cholinesterase (2 mg/kg). Indices of cholinergic synaptic development showed significant CPF-induced defects but only at doses above the threshold for cholinesterase inhibition. With earlier CPF treatment (GD9-12), there was no evidence of general fetotoxicity or alterations of brain cell development at doses up to the threshold for maternal toxicity (5 mg/kg), assessed on GD17 and GD21; however, augmentation of cholinergic synaptic markers was detected at doses as low as 1 mg/kg. Compared with previous work on postnatal CPF exposure, the effects seen here required doses closer to the threshold for fetal weight loss; this implies a lower vulnerability in the fetal compared with the neonatal brain. Although delayed neurotoxic effects of prenatal CPF may emerge subsequently in development, our results are consistent with the preferential targeting of late developmental events such as gliogenesis, axonogenesis, and synaptogenesis.

Full Text

The Full Text of this article is available as a PDF (560.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aschner M. Interactions between pesticides and glia: an unexplored experimental field. Neurotoxicology. 2000 Feb-Apr;21(1-2):175–180. [PubMed] [Google Scholar]
  2. Auman J. T., Seidler F. J., Slotkin T. A. Neonatal chlorpyrifos exposure targets multiple proteins governing the hepatic adenylyl cyclase signaling cascade: implications for neurotoxicity. Brain Res Dev Brain Res. 2000 May 11;121(1):19–27. doi: 10.1016/s0165-3806(00)00021-3. [DOI] [PubMed] [Google Scholar]
  3. Barone S., Jr, Das K. P., Lassiter T. L., White L. D. Vulnerable processes of nervous system development: a review of markers and methods. Neurotoxicology. 2000 Feb-Apr;21(1-2):15–36. [PubMed] [Google Scholar]
  4. Bomser J. A., Casida J. E. Diethylphosphorylation of rat cardiac M2 muscarinic receptor by chlorpyrifos oxon in vitro. Toxicol Lett. 2001 Feb 3;119(1):21–26. doi: 10.1016/s0378-4274(00)00294-0. [DOI] [PubMed] [Google Scholar]
  5. Bushnell P. J., Pope C. N., Padilla S. Behavioral and neurochemical effects of acute chlorpyrifos in rats: tolerance to prolonged inhibition of cholinesterase. J Pharmacol Exp Ther. 1993 Aug;266(2):1007–1017. [PubMed] [Google Scholar]
  6. Campbell C. G., Seidler F. J., Slotkin T. A. Chlorpyrifos interferes with cell development in rat brain regions. Brain Res Bull. 1997;43(2):179–189. doi: 10.1016/s0361-9230(96)00436-4. [DOI] [PubMed] [Google Scholar]
  7. Cermak J. M., Blusztajn J. K., Meck W. H., Williams C. L., Fitzgerald C. M., Rosene D. L., Loy R. Prenatal availability of choline alters the development of acetylcholinesterase in the rat hippocampus. Dev Neurosci. 1999;21(2):94–104. doi: 10.1159/000017371. [DOI] [PubMed] [Google Scholar]
  8. Chakraborti T. K., Farrar J. D., Pope C. N. Comparative neurochemical and neurobehavioral effects of repeated chlorpyrifos exposures in young and adult rats. Pharmacol Biochem Behav. 1993 Sep;46(1):219–224. doi: 10.1016/0091-3057(93)90344-s. [DOI] [PubMed] [Google Scholar]
  9. Chanda S. M., Pope C. N. Neurochemical and neurobehavioral effects of repeated gestational exposure to chlorpyrifos in maternal and developing rats. Pharmacol Biochem Behav. 1996 Apr;53(4):771–776. doi: 10.1016/0091-3057(95)02105-1. [DOI] [PubMed] [Google Scholar]
  10. Crumpton T. L., Seidler F. J., Slotkin T. A. Is oxidative stress involved in the developmental neurotoxicity of chlorpyrifos? Brain Res Dev Brain Res. 2000 Jun 30;121(2):189–195. doi: 10.1016/s0165-3806(00)00045-6. [DOI] [PubMed] [Google Scholar]
  11. Dam K., Garcia S. J., Seidler F. J., Slotkin T. A. Neonatal chlorpyrifos exposure alters synaptic development and neuronal activity in cholinergic and catecholaminergic pathways. Brain Res Dev Brain Res. 1999 Aug 5;116(1):9–20. doi: 10.1016/s0165-3806(99)00067-x. [DOI] [PubMed] [Google Scholar]
  12. Dam K., Seidler F. J., Slotkin T. A. Developmental neurotoxicity of chlorpyrifos: delayed targeting of DNA synthesis after repeated administration. Brain Res Dev Brain Res. 1998 Jun 15;108(1-2):39–45. doi: 10.1016/s0165-3806(98)00028-5. [DOI] [PubMed] [Google Scholar]
  13. Fenske R. A., Black K. G., Elkner K. P., Lee C. L., Methner M. M., Soto R. Potential exposure and health risks of infants following indoor residential pesticide applications. Am J Public Health. 1990 Jun;80(6):689–693. doi: 10.2105/ajph.80.6.689. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Garcia S. J., Seidler F. J., Crumpton T. L., Slotkin T. A. Does the developmental neurotoxicity of chlorpyrifos involve glial targets? Macromolecule synthesis, adenylyl cyclase signaling, nuclear transcription factors, and formation of reactive oxygen in C6 glioma cells. Brain Res. 2001 Feb 9;891(1-2):54–68. doi: 10.1016/s0006-8993(00)03189-9. [DOI] [PubMed] [Google Scholar]
  15. Garcia Stephanie J., Seidler Frederic J., Qiao Dan, Slotkin Theodore A. Chlorpyrifos targets developing glia: effects on glial fibrillary acidic protein. Brain Res Dev Brain Res. 2002 Feb 28;133(2):151–161. doi: 10.1016/s0165-3806(02)00283-3. [DOI] [PubMed] [Google Scholar]
  16. Guerri C., Renau-Piqueras J. Alcohol, astroglia, and brain development. Mol Neurobiol. 1997 Aug;15(1):65–81. doi: 10.1007/BF02740616. [DOI] [PubMed] [Google Scholar]
  17. Gurunathan S., Robson M., Freeman N., Buckley B., Roy A., Meyer R., Bukowski J., Lioy P. J. Accumulation of chlorpyrifos on residential surfaces and toys accessible to children. Environ Health Perspect. 1998 Jan;106(1):9–16. doi: 10.1289/ehp.981069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hohmann C. F., Berger-Sweeney J. Cholinergic regulation of cortical development and plasticity. New twists to an old story. Perspect Dev Neurobiol. 1998;5(4):401–425. [PubMed] [Google Scholar]
  19. Huff R. A., Corcoran J. J., Anderson J. K., Abou-Donia M. B. Chlorpyrifos oxon binds directly to muscarinic receptors and inhibits cAMP accumulation in rat striatum. J Pharmacol Exp Ther. 1994 Apr;269(1):329–335. [PubMed] [Google Scholar]
  20. Hunter D. L., Lassiter T. L., Padilla S. Gestational exposure to chlorpyrifos: comparative distribution of trichloropyridinol in the fetus and dam. Toxicol Appl Pharmacol. 1999 Jul 1;158(1):16–23. doi: 10.1006/taap.1999.8689. [DOI] [PubMed] [Google Scholar]
  21. Jett D. A., Navoa R. V. In vitro and in vivo effects of chlorpyrifos on glutathione peroxidase and catalase in developing rat brain. Neurotoxicology. 2000 Feb-Apr;21(1-2):141–145. [PubMed] [Google Scholar]
  22. Katoh S., Mitsui Y., Kitani K., Suzuki T. Hyperoxia induces the differentiated neuronal phenotype of PC12 cells by producing reactive oxygen species. Biochem Biophys Res Commun. 1997 Dec 18;241(2):347–351. doi: 10.1006/bbrc.1997.7514. [DOI] [PubMed] [Google Scholar]
  23. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  24. Labarca C., Paigen K. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem. 1980 Mar 1;102(2):344–352. doi: 10.1016/0003-2697(80)90165-7. [DOI] [PubMed] [Google Scholar]
  25. Landrigan P. J., Claudio L., Markowitz S. B., Berkowitz G. S., Brenner B. L., Romero H., Wetmur J. G., Matte T. D., Gore A. C., Godbold J. H. Pesticides and inner-city children: exposures, risks, and prevention. Environ Health Perspect. 1999 Jun;107 (Suppl 3):431–437. doi: 10.1289/ehp.99107s3431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Landrigan P. J. Pesticides and polychlorinated biphenyls (PCBs): an analysis of the evidence that they impair children's neurobehavioral development. Mol Genet Metab. 2001 May;73(1):11–17. doi: 10.1006/mgme.2001.3177. [DOI] [PubMed] [Google Scholar]
  27. Lassiter T. L., Padilla S., Mortensen S. R., Chanda S. M., Moser V. C., Barone S., Jr Gestational exposure to chlorpyrifos: apparent protection of the fetus? Toxicol Appl Pharmacol. 1998 Sep;152(1):56–65. doi: 10.1006/taap.1998.8514. [DOI] [PubMed] [Google Scholar]
  28. Lau C., Seidler F. J., Cameron A. M., Navarro H. A., Bell J. M., Bartolome J., Slotkin T. A. Nutritional influences on adrenal chromaffin cell development: comparison with central neurons. Pediatr Res. 1988 Nov;24(5):583–587. doi: 10.1203/00006450-198811000-00009. [DOI] [PubMed] [Google Scholar]
  29. Maurissen J. P., Hoberman A. M., Garman R. H., Hanley T. R., Jr Lack of selective developmental neurotoxicity in rat pups from dams treated by gavage with chlorpyrifos. Toxicol Sci. 2000 Oct;57(2):250–263. doi: 10.1093/toxsci/57.2.250. [DOI] [PubMed] [Google Scholar]
  30. Meneguz A., Bisso G. M., Michalek H. Alterations in the distribution of cholinesterase molecular forms in maternal and fetal brain following diisopropyl fluorophosphate treatment of pregnant rats. Neurochem Res. 1989 Mar;14(3):285–291. doi: 10.1007/BF00971325. [DOI] [PubMed] [Google Scholar]
  31. Mileson B. E., Chambers J. E., Chen W. L., Dettbarn W., Ehrich M., Eldefrawi A. T., Gaylor D. W., Hamernik K., Hodgson E., Karczmar A. G. Common mechanism of toxicity: a case study of organophosphorus pesticides. Toxicol Sci. 1998 Jan;41(1):8–20. doi: 10.1006/toxs.1997.2431. [DOI] [PubMed] [Google Scholar]
  32. Monnet-Tschudi F., Zurich M. G., Schilter B., Costa L. G., Honegger P. Maturation-dependent effects of chlorpyrifos and parathion and their oxygen analogs on acetylcholinesterase and neuronal and glial markers in aggregating brain cell cultures. Toxicol Appl Pharmacol. 2000 Jun 15;165(3):175–183. doi: 10.1006/taap.2000.8934. [DOI] [PubMed] [Google Scholar]
  33. Montoya D. A., White A. M., Williams C. L., Blusztajn J. K., Meck W. H., Swartzwelder H. S. Prenatal choline exposure alters hippocampal responsiveness to cholinergic stimulation in adulthood. Brain Res Dev Brain Res. 2000 Sep 30;123(1):25–32. doi: 10.1016/s0165-3806(00)00075-4. [DOI] [PubMed] [Google Scholar]
  34. Morley B. J., Happe H. K. Cholinergic receptors: dual roles in transduction and plasticity. Hear Res. 2000 Sep;147(1-2):104–112. doi: 10.1016/s0378-5955(00)00124-6. [DOI] [PubMed] [Google Scholar]
  35. Moser V. C., Chanda S. M., Mortensen S. R., Padilla S. Age- and gender-related differences in sensitivity to chlorpyrifos in the rat reflect developmental profiles of esterase activities. Toxicol Sci. 1998 Dec;46(2):211–222. doi: 10.1006/toxs.1998.2526. [DOI] [PubMed] [Google Scholar]
  36. Moser V. C., Padilla S. Age- and gender-related differences in the time course of behavioral and biochemical effects produced by oral chlorpyrifos in rats. Toxicol Appl Pharmacol. 1998 Mar;149(1):107–119. doi: 10.1006/taap.1997.8354. [DOI] [PubMed] [Google Scholar]
  37. Muto M. A., Lobelle F., Jr, Bidanset J. H., Wurpel J. N. Embryotoxicity and neurotoxicity in rats associated with prenatal exposure to DURSBAN. Vet Hum Toxicol. 1992 Dec;34(6):498–501. [PubMed] [Google Scholar]
  38. Navarro H. A., Seidler F. J., Eylers J. P., Baker F. E., Dobbins S. S., Lappi S. E., Slotkin T. A. Effects of prenatal nicotine exposure on development of central and peripheral cholinergic neurotransmitter systems. Evidence for cholinergic trophic influences in developing brain. J Pharmacol Exp Ther. 1989 Dec;251(3):894–900. [PubMed] [Google Scholar]
  39. Padilla S., Buzzard J., Moser V. C. Comparison of the role of esterases in the differential age-related sensitivity to chlorpyrifos and methamidophos. Neurotoxicology. 2000 Feb-Apr;21(1-2):49–56. [PubMed] [Google Scholar]
  40. Pope C. N., Chakraborti T. K., Chapman M. L., Farrar J. D., Arthun D. Comparison of in vivo cholinesterase inhibition in neonatal and adult rats by three organophosphorothioate insecticides. Toxicology. 1991;68(1):51–61. doi: 10.1016/0300-483x(91)90061-5. [DOI] [PubMed] [Google Scholar]
  41. Pope C. N., Chakraborti T. K. Dose-related inhibition of brain and plasma cholinesterase in neonatal and adult rats following sublethal organophosphate exposures. Toxicology. 1992;73(1):35–43. doi: 10.1016/0300-483x(92)90168-e. [DOI] [PubMed] [Google Scholar]
  42. Pope C. N. Organophosphorus pesticides: do they all have the same mechanism of toxicity? J Toxicol Environ Health B Crit Rev. 1999 Apr-Jun;2(2):161–181. doi: 10.1080/109374099281205. [DOI] [PubMed] [Google Scholar]
  43. Qiao D., Seidler F. J., Slotkin T. A. Developmental neurotoxicity of chlorpyrifos modeled in vitro: comparative effects of metabolites and other cholinesterase inhibitors on DNA synthesis in PC12 and C6 cells. Environ Health Perspect. 2001 Sep;109(9):909–913. doi: 10.1289/ehp.01109909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Ray D. E., Richards P. G. The potential for toxic effects of chronic, low-dose exposure to organophosphates. Toxicol Lett. 2001 Mar 31;120(1-3):343–351. doi: 10.1016/s0378-4274(01)00266-1. [DOI] [PubMed] [Google Scholar]
  45. Rice D., Barone S., Jr Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect. 2000 Jun;108 (Suppl 3):511–533. doi: 10.1289/ehp.00108s3511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Rodier P. M. Structural--functional relationships in experimentally induced brain damage. Prog Brain Res. 1988;73:335–348. doi: 10.1016/S0079-6123(08)60514-2. [DOI] [PubMed] [Google Scholar]
  47. Roy T. S., Andrews J. E., Seidler F. J., Slotkin T. A. Chlorpyrifos elicits mitotic abnormalities and apoptosis in neuroepithelium of cultured rat embryos. Teratology. 1998 Aug;58(2):62–68. doi: 10.1002/(SICI)1096-9926(199808)58:2<62::AID-TERA7>3.0.CO;2-2. [DOI] [PubMed] [Google Scholar]
  48. Slotkin T. A., Cousins M. M., Tate C. A., Seidler F. J. Persistent cholinergic presynaptic deficits after neonatal chlorpyrifos exposure. Brain Res. 2001 Jun 1;902(2):229–243. doi: 10.1016/s0006-8993(01)02387-3. [DOI] [PubMed] [Google Scholar]
  49. Slotkin T. A. Developmental cholinotoxicants: nicotine and chlorpyrifos. Environ Health Perspect. 1999 Feb;107 (Suppl 1):71–80. doi: 10.1289/ehp.99107s171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Song X., Seidler F. J., Saleh J. L., Zhang J., Padilla S., Slotkin T. A. Cellular mechanisms for developmental toxicity of chlorpyrifos: targeting the adenylyl cyclase signaling cascade. Toxicol Appl Pharmacol. 1997 Jul;145(1):158–174. doi: 10.1006/taap.1997.8171. [DOI] [PubMed] [Google Scholar]
  51. Song X., Violin J. D., Seidler F. J., Slotkin T. A. Modeling the developmental neurotoxicity of chlorpyrifos in vitro: macromolecule synthesis in PC12 cells. Toxicol Appl Pharmacol. 1998 Jul;151(1):182–191. doi: 10.1006/taap.1998.8424. [DOI] [PubMed] [Google Scholar]
  52. Trauth J. A., Seidler F. J., Slotkin T. A. An animal model of adolescent nicotine exposure: effects on gene expression and macromolecular constituents in rat brain regions. Brain Res. 2000 Jun 9;867(1-2):29–39. doi: 10.1016/s0006-8993(00)02208-3. [DOI] [PubMed] [Google Scholar]
  53. Vallés S., Pitarch J., Renau-Piqueras J., Guerri C. Ethanol exposure affects glial fibrillary acidic protein gene expression and transcription during rat brain development. J Neurochem. 1997 Dec;69(6):2484–2493. doi: 10.1046/j.1471-4159.1997.69062484.x. [DOI] [PubMed] [Google Scholar]
  54. Ward T. R., Mundy W. R. Organophosphorus compounds preferentially affect second messenger systems coupled to M2/M4 receptors in rat frontal cortex. Brain Res Bull. 1996;39(1):49–55. doi: 10.1016/0361-9230(95)02044-6. [DOI] [PubMed] [Google Scholar]
  55. Whitney K. D., Seidler F. J., Slotkin T. A. Developmental neurotoxicity of chlorpyrifos: cellular mechanisms. Toxicol Appl Pharmacol. 1995 Sep;134(1):53–62. doi: 10.1006/taap.1995.1168. [DOI] [PubMed] [Google Scholar]
  56. Winick M., Noble A. Quantitative changes in DNA, RNA, and protein during prenatal and postnatal growth in the rat. Dev Biol. 1965 Dec;12(3):451–466. doi: 10.1016/0012-1606(65)90009-6. [DOI] [PubMed] [Google Scholar]
  57. Zawia N. H., Harry G. J. Developmental exposure to lead interferes with glial and neuronal differential gene expression in the rat cerebellum. Toxicol Appl Pharmacol. 1996 May;138(1):43–47. doi: 10.1006/taap.1996.0095. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES